Recommendations to assure the quality, safety and efficacy of Group A Meningococcal Conjugate vaccines

ECBS 2006

Recommendations for the production and control of group C meningococcal conjugate vaccines, TRS 926, Annex 3

Recommendations for the production and control of Meningococcal group C conjugate vaccines, TRS 924, 2004, Annex 2

Requirements for Meningococcal Polysaccharide vaccine (Amendment 1999) TRS 904, 2002 Annex 2

Requirements for meningococcal polysaccharide vaccine, Addendum 1980, TRS 658 Annex 6

Requirements for Meningococcal Polysaccharide vaccine: Adopted 1975, TRS 594, Annex 2


  • Working Group Meeting to develop WHO Guidelines on regulatory preparedness for vaccine non-producing countries in response to Pandemic Influenza emergency, 9-11 June 2015, Tunis Conference Centre, Tunisia


Technologies Standards and Norms (TSN)
Essential Medicines and Health Products (EMP)
World Health Organization (WHO)
Avenue Appia 20
1211 Geneva 27, Switzerland
Fax No. +41 22 7914971